Cargando…
Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial
BACKGROUND: Coronary artery diseases (CAD) remains a severe socio-economic burden in the Western world. Coronary obstruction and subsequent myocardial ischemia result in progressive replacement of contractile myocardium with dysfunctional, fibrotic scar tissue. Post-infarctional remodeling is causal...
Autores principales: | Pölzl, Leo, Nägele, Felix, Graber, Michael, Hirsch, Jakob, Lobenwein, Daniela, Mitrovic, Martina, Mayr, Agnes, Theurl, Markus, Schreinlechner, Michael, Pamminger, Matthias, Dorfmüller, Christian, Grimm, Michael, Gollmann-Tepeköylü, Can, Holfeld, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260800/ https://www.ncbi.nlm.nih.gov/pubmed/32473644 http://dx.doi.org/10.1186/s13063-020-04369-0 |
Ejemplares similares
-
Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial—an update
por: Nägele, Felix, et al.
Publicado: (2022) -
Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
por: Graber, Michael, et al.
Publicado: (2022) -
Shockwaves prevent from heart failure after acute myocardial ischaemia via
RNA/protein complexes
por: Tepeköylü, Can, et al.
Publicado: (2016) -
Defining a therapeutic range for regeneration of ischemic myocardium via shock waves
por: Pölzl, Leo, et al.
Publicado: (2021) -
Shock Wave Therapy Improves Cardiac Function in a Model of Chronic Ischemic Heart Failure: Evidence for a Mechanism Involving VEGF Signaling and the Extracellular Matrix
por: Gollmann‐Tepeköylü, Can, et al.
Publicado: (2018)